With regard to mechanism of the UPR in promoting cancer, simultaneous evaluation of EVTF and/or TF procoagulant activity along with validated UPR markers will be useful in assessing the hypothesis that UPR contributes to CAT by stimulating the generation of EVTF. The gene discussed is TF; the disease is cancer.